ResearcherUniversity of SassariNo recent work listed
Mario Sechi
Matched on ORCID iD 0000-0003-2983-6090; OpenAlex author ID A5040046127. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper
Papers 4
- Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma. First author DOI 10.1021/acs.jmedchem.7b01463↗
- Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells. Last author DOI 10.1021/acs.jmedchem.5b01571↗
- Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells. Co-author DOI 10.1111/bph.12855↗
- Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer. First author DOI 10.1016/j.bbagen.2013.08.005↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nouri Neamati · 4 shared papers, 2014–2018 · strength 0.29
- Paper Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma. DOI 10.1021/acs.jmedchem.7b01463↗
- Paper Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer c… DOI 10.1111/bph.12855↗
- Paper Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells. DOI 10.1021/acs.jmedchem.5b01571↗
- Divya Pathania · 3 shared papers, 2014–2016 · strength 0.18
- Paper Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer c… DOI 10.1111/bph.12855↗
- Paper Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells. DOI 10.1021/acs.jmedchem.5b01571↗
- Paper Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer. DOI 10.1016/j.bbagen.2013.08.005↗
- Yuting Kuang · 2 shared papers, 2015–2018 · strength 0.18
- Paper Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma. DOI 10.1021/acs.jmedchem.7b01463↗
- Paper Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer c… DOI 10.1111/bph.12855↗
- Vanna Sanna · 2 shared papers, 2014–2016 · strength 0.11
- Mats E. Ljungman · 1 shared paper, 2018 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.